Phase II trial of tamoxifen in chronic lymphocytic leukemia. 1986

F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
April 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
January 1975, Cancer chemotherapy reports,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
December 2009, Leukemia & lymphoma,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
January 2010, Leukemia,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
April 2009, Leukemia & lymphoma,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
February 1985, The American journal of medicine,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
June 1993, Leukemia & lymphoma,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
August 2000, American journal of clinical oncology,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
November 2005, Leukemia,
F Al-Gailani, and R J Marder, and J A Radosevich, and W W Hauck, and A Molteni, and S T Rosen
April 2007, Cancer biotherapy & radiopharmaceuticals,
Copied contents to your clipboard!